Adding a test for human papillomavirus DNA to cervical cancer screening.

被引：179
作者：
Wright, TC
Schiffman, M
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[2] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 06期
关键词：
D O I：
10.1056/NEJMp020178
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：489 / 490
页数：2
相关论文
共 3 条
[1]   A controlled trial of a human papillomavirus type 16 vaccine [J].
Koutsky, LA ;
Ault, KA ;
Wheeler, CM ;
Brown, DR ;
Barr, E ;
Alvarez, FB ;
Chiacchierini, LM ;
Jansen, KU .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1645-1651
[2]   Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis [J].
Sherman, ME ;
Lorincz, AT ;
Scott, DR ;
Wacholder, S ;
Castle, PE ;
Glass, AG ;
Mielzynska-Lohnas, I ;
Rush, BB ;
Schiffman, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (01) :46-52
[3]   2001 consensus guidelines for the management of women with cervical cytological abnormalities [J].
Wright, TC ;
Cox, JT ;
Massad, LS ;
Twiggs, LB ;
Wilkinson, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (16) :2120-2129
1